[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357024-105":59,"doc-detail-357024-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","emerging-agents-that-target-signaling-pathways-in-cancer-fibroblast-cells-review","Emerging agents that target signaling pathways in cancer fibroblast cells - Review","","Cancer-associated fibroblasts (CAFs) drive tumor development, recurrence, and metastasis through multiple signaling pathways. Key routes include FAP, PI3K/AKT/mTOR, JAK/STAT, NF-κB, TGF-β, and cell-death programs such as ferroptosis, apoptosis, and autophagy. Inhibiting these pathways can suppress CAF protumor functions, while small-molecule drugs offer favorable dispersion, druggability, and pharmacokinetics. This review consolidates small-molecule evidence against CAF progression, highlighting targeted therapeutic strategies for clinical translation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerging-agents-that-target-signaling-pathways-in-cancer-fibroblast-cells-review/357024/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerging-agents-that-target-signaling-pathways-in-cancer-fibroblast-cells-review/357024.png","ImageObject",300,407,{"name":92,"@type":93},"Mabel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What roles do cancer-associated fibroblasts (CAFs) play in cancer?","Question",{"text":113,"@type":114},"CAFs promote cancer initiation and progression by remodeling the extracellular matrix, supporting stemness, regulating angiogenesis, metabolism, and immune responses, and enhancing proliferation, migration, invasion, and therapy resistance.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which signaling pathways are highlighted as crucial in CAF development?",{"text":118,"@type":114},"The review emphasizes pathways including FAP, PI3K/AKT/mTOR, JAK/STAT, NF-κB, and TGF-β, along with ferroptosis, apoptosis, and autophagy-related pathways.",{"name":120,"@type":111,"acceptedAnswer":121},"How do small-molecule drugs relate to targeting CAFs?",{"text":122,"@type":114},"Small-molecule compounds are discussed as druggable agents with favorable spatial structures and distinct chemical properties, and they are summarized as inhibitors or activators affecting CAF progression-related pathways.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},357024,1790188969,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","INTERNATIONAL JOURNAL OF ONCOLOGY 69: 87, 2026  \nEmerging agents that target signaling pathways in cancer fibroblast cells (Review)  \nYAN WAN 1* , XIANG‑QING LIU 1* , DONG LIU2 , KE‑DI LI2 and DAN‑DAN ZHANG2  \n1School of Pharmacy, Anhui College of Traditional Chinese Medicine, Wuhu, Anhui 241000, P.R. China; 2School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, P.R. China  \nReceived November 14, 2025; Accepted March 24, 2026  \nDOI: 10.3892/ijo.2026.5900  \nAbstract. Cancer‑associated fibroblasts (CAFs) play a critical role in cancer development, recurrence and metastasis. Several signaling pathways are crucial in CAF development, including fibroblast activation protein (FAP), phosphoinositide 3‑kinase (PI3K)/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR), Janus kinase/signal transducers and activators of transcription (JAK/STAT), nuclear factor κB (NF‑κB), transforming growth factor β (TGF‑β), ferroptosis, apoptosis and autophagy pathways. Targeting the ferroptosis signaling pathway specifically kills CAFs. Therefore, targeting these pathways may inhibit the protumorigenic functions of CAFs. Small molecule drugs, due to their well‑dispersed spatial structures and distinct chemical properties, exhibit promising druggability and pharmacokinetic profiles. These characteristics make small molecule drugs highly advanta‑ geous in drug development and increasingly favored in the market. The present review summarized current studies on small molecule compounds that inhibit CAF progression, encompassing inhibitors of the PI3K/AKT/mTOR, JAK/STAT, TGF‑β and NF‑κB pathways, as well as activators of the FAP, ferroptosis, apoptosis and autophagy pathways. These small molecule compounds underscore the significance of CAFsin tumor progression and suggest novel strategies for cancer treatment by targeting CAFs in clinical settings.  \nContents  \n1. Introduction  \n2. Signaling pathway regulators  \nCorrespondence to: Dr Yan Wan, School of Pharmacy, Anhui College of Traditional Chinese Medicine, 18 Wuxia West Road, Wuhu, Anhui 241000, P.R. China  \nE‑mail: [15592038985@163.com](15592038985@163.com)  \n*Contributed equally  \nKey words: cancer‑associated fibroblasts, small molecule drugs, signaling pathways, ferroptosis  \n3. Other signaling pathways or target regulators  \n4. Selective inducers of cell death  \n5. CAFs heterogeneity and therapeutic risks: A detailed analysis  \n6. Discussion  \n1. Introduction  \nCancer remains a leading cause of mortality worldwide, with the World Health Organization reporting nearly 10 million deaths in 2020, accounting for ~1 in 6 fatalities globally (1) . Despite the efficacy of conventional therapies in markedly reducing tumor burden, recurrence and metastasis frequently occur, ultimately resulting in treatment failure. A major factor contributing to this failure is the inadequate consideration or neglect of the tumor microenvironment (TME) in antitumor strategies (2) . The TME comprises various immune cell populations, cancer‑associated fibroblasts (CAFs), endothelial cells, pericytes and a diverse array of other tissue‑resident cell types . Historically regarded as passive bystanders in tumorigenesis, these host cells are now recognized as critical players in cancer pathogenesis. The cellular composition and functional states of the TME vary markedly depending on the organ of tumor origin, intrinsic characteristics of cancer cells, tumor stage and patient‑specific factors (3) . Among TME components, CAFs are pivotal in cancer initiation and progression, owing to their multifaceted roles in extracellular matrix (ECM) remodeling, maintenance of stemness prop‑ erties, angiogenesis, modulation of tumor metabolism and immune responses, as well as their promotion of cancer cell proliferation, migration, invasion and therapeutic resistance. CAFs represent a highly heterogeneous stromal population, engaging in complex and intricate crosstalk with cancer cells mediate","cbCaioHEMAICgn1Z","https://ap.wps.com/l/cbCaioHEMAICgn1Z","pdf",2143945,25,"English","# Introduction\n## Signaling pathway regulators\n## Other signaling pathways or target regulators\n## Selective inducers of cell death\n## CAFs heterogeneity and therapeutic risks: A detailed analysis\n## Discussion","[{\"question\":\"What roles do cancer-associated fibroblasts (CAFs) play in cancer?\",\"answer\":\"CAFs promote cancer initiation and progression by remodeling the extracellular matrix, supporting stemness, regulating angiogenesis, metabolism, and immune responses, and enhancing proliferation, migration, invasion, and therapy resistance.\"},{\"question\":\"Which signaling pathways are highlighted as crucial in CAF development?\",\"answer\":\"The review emphasizes pathways including FAP, PI3K/AKT/mTOR, JAK/STAT, NF-κB, and TGF-β, along with ferroptosis, apoptosis, and autophagy-related pathways.\"},{\"question\":\"How do small-molecule drugs relate to targeting CAFs?\",\"answer\":\"Small-molecule compounds are discussed as druggable agents with favorable spatial structures and distinct chemical properties, and they are summarized as inhibitors or activators affecting CAF progression-related pathways.\"}]","Emerging agents that target signaling pathways in cancer fibroblast cells - Review | PDF",1790128635,63,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b9dcb403cc779d5f88d63bf8a598940.webp",983,1357,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7056502bede5b80dc9900bf7e49ffcbe.webp",982,1356,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc73264df10f66b3318c722802f97758.webp",981,1354,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/408566e0467c4976e2c06706eb7c838c.webp",980,1353]